Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 160

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia

Open access
George, Tony P., Vessicchio, Jennifer C., Sacco, Kristi A., Weinberger, Andrea H., Dudas, Melissa M., Allen, Taryn M., Creeden, Cerissa L., Potenza, Marc N., Feingold, Alan, Jatlow, Peter I. · 2008 · Biological Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2007.11.002

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 22

  1. Dalack, 1998, Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings, Am J Psychiatry, 155, 1490, 10.1176/ajp.155.11.1490 · DOI · Paper page
  2. Ziedonis, 2003, Management of smoking in people with psychiatric disorders, Curr Opin Psychiatry, 16, 305, 10.1097/01.yco.0000069086.26384.5f · DOI
  3. Lasser, 2000, Smoking and mental illness: A population-based prevalence study, JAMA, 284, 2606, 10.1001/jama.284.20.2606 · DOI · Paper page
  4. Ascher, 1995, Bupropion: A review of its mechanism of antidepressant activity, J Clin Psychiatry, 56, 395
  5. Ferry, 1994, Efficacy of bupropion for smoking cessation in non-depressed smokers, J Addict Dis, 13, 249
  6. Hurt, 1997, A comparison of sustained-release bupropion and placebo for smoking cessation, N Engl J Med, 337, 1195, 10.1056/NEJM199710233371703 · DOI · Paper page
  7. Addington, 1998, Smoking cessation treatment for patients with schizophrenia, Am J Psychiatry, 155, 974, 10.1176/ajp.155.7.974 · DOI · Paper page
  8. Chou, 2004, The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia, Int J Nurs Stud, 41, 321, 10.1016/j.ijnurstu.2003.07.001 · DOI
  9. Evins, 2005, A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia, J Clin Psychopharmacol, 25, 218, 10.1097/01.jcp.0000162802.54076.18 · DOI · Paper page
  10. Fatemi, 2005, A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia, Schizophr Res, 76, 353, 10.1016/j.schres.2005.02.021 · DOI
  11. George, 2000, Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia, Am J Psychiatry, 157, 1835, 10.1176/appi.ajp.157.11.1835 · DOI · Paper page
  12. George, 2002, A placebo-controlled study of bupropion for smoking cessation in schizophrenia, Biol Psychiatry, 52, 53, 10.1016/S0006-3223(02)01339-2 · DOI · Paper page
  13. Breese, 2000, Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia, Neuropsychopharmacology, 23, 351, 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
  14. Leonard, 2002, Promoter variants in the alpha-7 nicotinic acetylcholine receptor subunit gene are associated with an inhibitory deficit found in schizophrenia, Arch Gen Psychiatry, 59, 1085, 10.1001/archpsyc.59.12.1085 · DOI · Paper page
  15. Sacco, 2005, Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: Involvement of nicotinic receptor mechanisms, Arch Gen Psychiatry, 62, 649, 10.1001/archpsyc.62.6.649 · DOI · Paper page
  16. Biener, 1991, The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation, Health Psychol, 10, 360, 10.1037/0278-6133.10.5.360 · DOI · Paper page
  17. Sobell, 1988, Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations, Brit J Addict, 83, 393, 10.1111/j.1360-0443.1988.tb00485.x · DOI · Paper page
  18. Bland, 1998, Survival probabilities (the Kaplan-Meier method), BMJ, 317, 1572, 10.1136/bmj.317.7172.1572 · DOI · Paper page
  19. Hughes, 2003, Measurement of abstinence in clinical trials: issues and recommendations, Nicotine Tobacco Res, 5, 13, 10.1093/ntr/5.1.13 · DOI · Paper page
  20. Kapur, 1991, Use of random sequence riboflavin as a marker of medication compliance in chronic schizophrenics, Schizophr Res, 6, 49, 10.1016/0920-9964(91)90020-R · DOI
  21. de Leon, 2004, Atypical antipsychotic dosing: The effect of smoking and caffeine, Psychiatr Serv, 55, 491, 10.1176/appi.ps.55.5.491 · DOI
  22. Kotylar, 2005, Inhibition of CYP2D6 activity by bupropion, J Cin Psychopharmcol, 25, 226, 10.1097/01.jcp.0000162805.46453.e3 · DOI

Cited by

See all 160

Metadata

Authors
George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2008-06
Volume
63
Issue
11
Pages
1092-1096
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2044741201
Cited by
160
References
10
FWCI
7.32
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia. https://app.cochat.ai/papers/10.1016/j.biopsych.2007.11.002
The paper
George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I. (2008). A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2007.11.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.